The pattern of cytoplasmic IgM expression in the context of the three currently recognised maturational stages of hematogones

Leukemia and Lymphoma

Volumn 50, Issue 4, 2009, Pages 642-644

  Sevilla, Deborah W ^a   Emmons, Foxwell N ^a   Bai, Xiaolin ^a   Colovai, Adriana ^a   Bhagat, Govind ^a   Alobeid, Bachir ^a  

^a NewYork Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; CD34 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; DNA NUCLEOTIDYLEXOTRANSFERASE; IMMUNOGLOBULIN M; LEUKOSIALIN;

ACUTE BIPHENOTYPIC LEUKEMIA; ACUTE LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ANTIGEN EXPRESSION; APLASTIC ANEMIA; ARTICLE; BONE MARROW BIOPSY; CELL MATURATION; EMBRYONAL RHABDOMYOSARCOMA; FLOW CYTOMETRY; HEMATOGONE; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HUMAN; LARGE CELL LYMPHOMA; LYMPHOBLAST; MULTIPLE MYELOMA; PHENOTYPE; PRE B LYMPHOCYTE; PRIORITY JOURNAL;

ANTIGENS, CD19; B-LYMPHOCYTES; BONE MARROW CELLS; CYTOPLASM; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOGLOBULIN M; NEPRILYSIN;

EID: 68449103041     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190802699357     Document Type: Article

References (10)

1. McKenna RW, Washington LT, Aquino DB, Picker LJ, Kroft SH. Immunophenotypic analysis of hematogones (B-lymphocyte precursors) in 662 consecutive bone marrow specimens by 4-color flow cytometry. Blood 2001;98:2498-2507.
2. Longacre TA, Foucar K, Crago S, Chen IM, Griffith B, Dressler L, et al. Hematogones: A multiparameter analysis of bone marrow precursor cells. Blood 1989;73:543-552.
3. Weir EG, Cowan K, LeBeau P, Borowitz MJ. A limited antibody panel can distinguish B-precursor acute lymphoblastic leukemia from normal B precursors with four color flow cytometry: Implications for residual disease detection. Leukemia 1999;13:558-567.
4. Rimsza LM, Larson RS, Winter SS, Foucar K, Chong YY, Garner KW, et al. Benign hematogone-rich lymphoid proliferations can be distinguished from B-lineage acute lymphoblastic leukemia by integration of morphology, immunophenotype, adhesion molecule expression, and architectural features. Am J Clin Pathol 2000;114:66-75.
5. Chen W, Karandikar NJ, McKenna RW, Kroft SH. Stability of leukemia-associated immunophenotypes in precursor B-lymphoblastic leukemia/lymphoma: A single institution experience. Am J Clin Pathol 2007;127:39-46.
6. van Wering ER, van der Linden-Schrever BE, Szczepanski T, Willemse MJ, Baars EA, van Wijngaarde-Schmitz HM, et al. Regenerating normal B-cell precursors during and after treatment of acute lymphoblastic leukaemia: implications for monitoring of minimal residual disease. Br J Haematol 2000;110:139-146.
7. Gathings WE, Lawton AR, Cooper MD. Immunofluorescent studies of the development of pre-B cells, B lymphocytes and immunoglobulin isotype diversity in humans. Eur J Immunol 1977;7:804-810.
8. Pearl ER, Vogler LB, Okos AJ, Crist WM, Lawton AR, Cooper MD. B lymphocyte precursors in human bone marrow: An analysis of normal individuals and patients with antibody-deficiency states. J Immunol 1978;120:1169-1175.
9. LeBien TW. Fates of human B-cell precursors. Blood 2000;96:9-23.
10. Tsao L, Colovai AI, Jiang JG, Bhagat G, Alobeid B. Characterizing CD43 expression in haematogones using multicolor flow cytometric analysis. Br J Haematol 2005; 128:820-823.